LiveRamp RAMP
$38.50 +$0.00 (0.00%)
Market closed · Nov 19, 8:00 pm ET
Open$0.00
Prev close$38.50
Day range$0.00 – $0.00
Volume0.00
Market cap$2.35B
P/E (TTM)16.7
Dividend yield–
RAMP Stock News
Headlines matching LiveRamp(Delisted) or the RAMP ticker, most recent first.
- Goldman Sachs: Maintains "Buy" rating on Biren Technology (06082) with a target price of HK$80.5; AI chip shipments continue to ramp up
- Eoptolink (300502): Volume ramp-up of 800G/1.6T products drives performance realization; AI optical interconnect leader enters accelerated growth phase Positive
- Beijiajie (603059): Ramp-up phase temporarily pressures profitability; medium- to long-term outlook remains positive for probiotics business.
- Yangnong Chemical (600486): The company maintains steady performance; we are optimistic about the capacity ramp-up of its Youchuang project. Positive
- Amlogic Inc. (688099): Core products continue to ramp up volume; Q2 performance surges significantly year-on-year and quarter-on-quarter Positive
- Guangwei Composites (300699): Ramp-up of high-end new models supports steady earnings growth, securing a position in the high-growth tracks of domestic large aircraft and commercial aerospace. Positive
- Jianghai Co., Ltd. (002484): Accelerated Ramp-up of Film and Supercapacitor Shipments; Data Center Applications Open Up Growth Potential Positive
- Shenzhou International (2313.HK): Focus on the ramp-up of new overseas production capacity and contributions from new clients in the future.
- Yue'an New Materials (688786.SH): Ningxia Yue'an's 3,000-ton carbonyl iron powder demonstration line is currently in the commissioning and ramp-up phase.
- Kesun Corp. (300856): Recovery in Sunscreen Demand and Ramp-up in Personal Care Ingredients; Price Competition and FX Gains/Losses Weigh on Profitability Mixed
- Senqilin (002984): The company's short-term performance is under pressure, but we remain optimistic about the ramp-up of production capacity at its Moroccan plant and the expansion of downstream customer base. Positive
- Morgan Stanley Maintains LiveRamp(RAMP.US) With Hold Rating, Maintains Target Price $38.5
- Horizonrobot-W (09660.HK): Smart driving chip shipments continue to ramp up, accelerating expansion into sectors beyond automotive. Positive
- Bokai New Materials (300811): Q2 performance shows significant quarter-on-quarter improvement; AI chip inductors enter a phase of accelerated volume ramp-up.
- Hua Medicine-B (2552.HK): Huatingning continues to ramp up sales; U.S. clinical data for the second-generation GKA expected to be released within the year.
No comments yet — be the first to weigh in on RAMP.
Sign in to join the discussion.